257 related articles for article (PubMed ID: 35500538)
21. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation.
Carvalho GB; Pacífico LG; Pimenta DL; Siqueira LM; Teixeira-Carvalho A; Coelho PM; Pinheiro Cda S; Fujiwara RT; Oliveira SC; Fonseca CT
Exp Parasitol; 2014 Apr; 139():24-32. PubMed ID: 24560833
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of Schistosoma mansoni tegument annexins and comparative analysis of antibody responses following parasite infection.
Leow CY; Willis C; Leow CH; Hofmann A; Jones M
Mol Biochem Parasitol; 2019 Dec; 234():111231. PubMed ID: 31628972
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
Ahmad G; Zhang W; Torben W; Noor Z; Siddiqui AA
Int J Infect Dis; 2010 Sep; 14(9):e781-7. PubMed ID: 20630783
[TBL] [Abstract][Full Text] [Related]
24. Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase.
Tallima H; Dvořák J; Kareem S; Abou El Dahab M; Abdel Aziz N; Dalton JP; El Ridi R
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005443. PubMed ID: 28346516
[TBL] [Abstract][Full Text] [Related]
25. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
Rezende CM; Silva MR; Santos IG; Silva GA; Gomes DA; Goes AM
Immunol Lett; 2011 Dec; 141(1):123-33. PubMed ID: 21945176
[TBL] [Abstract][Full Text] [Related]
26. Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection.
Figueiredo BC; Assis NR; Morais SB; Ricci ND; Pinheiro CS; Martins VP; Bicalho RM; Da'dara AA; Skelly PJ; Oliveira SC
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3107. PubMed ID: 25144756
[TBL] [Abstract][Full Text] [Related]
27. Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine.
Ahmad G; Zhang W; Torben W; Haskins C; Diggs S; Noor Z; Le L; Siddiqui AA
Parasitol Res; 2009 Nov; 105(6):1767-77. PubMed ID: 19809833
[TBL] [Abstract][Full Text] [Related]
28. Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to Schistosomiasis.
El Ridi R; Mahrous A; Afifi A; Montash M; Velek J; Jezek J
Scand J Immunol; 2001 Nov; 54(5):477-85. PubMed ID: 11696199
[TBL] [Abstract][Full Text] [Related]
29. Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse.
Zhang W; Ahmad G; Torben W; Siddiqui AA
Parasite Immunol; 2010 Apr; 32(4):252-8. PubMed ID: 20398225
[TBL] [Abstract][Full Text] [Related]
30. Defined Intestinal Regions Are Drained by Specific Lymph Nodes That Mount Distinct Th1 and Th2 Responses Against
Mayer JU; Brown SL; MacDonald AS; Milling SW
Front Immunol; 2020; 11():592325. PubMed ID: 33193437
[TBL] [Abstract][Full Text] [Related]
31. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
Tallima H; Tadros MM; El Ridi R
Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
[TBL] [Abstract][Full Text] [Related]
32. Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.
Farias LP; Cardoso FC; Miyasato PA; Montoya BO; Tararam CA; Roffato HK; Kawano T; Gazzinelli A; Correa-Oliveira R; Coulson PS; Wilson RA; Oliveira SC; Leite LC
PLoS Negl Trop Dis; 2010 Feb; 4(2):e597. PubMed ID: 20161725
[TBL] [Abstract][Full Text] [Related]
33. Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons.
Rojo JU; Melkus MW; Kottapalli KR; Okiya OE; Sudduth J; Zhang W; Molehin AJ; Carter D; Siddiqui AA
PLoS One; 2017; 12(2):e0171677. PubMed ID: 28192534
[TBL] [Abstract][Full Text] [Related]
34. Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni.
Ranasinghe SL; Duke M; Harvie M; McManus DP
Int J Infect Dis; 2018 Jan; 66():26-32. PubMed ID: 29128645
[TBL] [Abstract][Full Text] [Related]
35. Heat-killed Propionibacterium acnes augment the protective effect of 28-kDa glutathione S-transferases antigen against Schistosoma mansoni infection.
Lam HYP; Yang TH; Liang TR; Cheng PC; Chang KC; Peng SY
Acta Trop; 2021 Oct; 222():106033. PubMed ID: 34224719
[TBL] [Abstract][Full Text] [Related]
36. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
[TBL] [Abstract][Full Text] [Related]
37. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.
Garcia TC; Fonseca CT; Pacifico LG; Durães Fdo V; Marinho FA; Penido ML; Caliari MV; de Melo AL; Pinto HA; Barsante MM; Cunha-Neto E; Oliveira SC
Acta Trop; 2008 Jun; 106(3):162-7. PubMed ID: 18423420
[TBL] [Abstract][Full Text] [Related]
38. Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni.
Ahmad G; Torben W; Zhang W; Wyatt M; Siddiqui AA
Parasite Immunol; 2009 Mar; 31(3):156-61. PubMed ID: 19222788
[TBL] [Abstract][Full Text] [Related]
39. Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model.
Dzhivhuho GA; Rehrl SA; Ndlovu H; Horsnell WGC; Brombacher F; Williamson AL; Chege GK
PLoS Pathog; 2018 Jul; 14(7):e1007182. PubMed ID: 30048550
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
